Digital Mindfulness Meditation-enhanced Cognitive Behavioral Therapy (CBT-MM) for Binge Eating Disorder
Launched by YESHIVA UNIVERSITY · Sep 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment approach for Binge Eating Disorder (BED) that combines mindfulness meditation with cognitive behavioral therapy (CBT). This 18-week program will be delivered digitally, allowing participants to engage with the therapy from their own homes. The main goal of the trial is to see how acceptable and practical this treatment is for people with BED, which means they frequently eat large amounts of food even when they are not hungry and may feel a lack of control over their eating.
To be eligible for the study, participants need to be at least 18 years old and must meet specific criteria for Binge Eating Disorder. They should also be able to speak and understand English. However, people with a very low body mass index (BMI), those who are currently pregnant or breastfeeding, or those receiving treatment for other eating disorders will not be able to participate. If you join the study, you can expect to take part in an innovative therapy designed to help manage binge eating, and your experiences will help researchers improve the program for future studies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older
- • Meeting DSM-5 criteria for Binge Eating Disorder (BED)
- • English-speaking
- Exclusion Criteria:
- • BMI \< 18.5
- • Requiring immediate treatment for medical complications
- • Current anorexia or bulimia nervosa or purging behaviors within the past year
- • Already receiving treatment for an ED or participating in a weight loss program or psychotherapy focused on weight (psychotherapy for other conditions was allowed)
- • Currently pregnant or breast-feeding
- • Experiencing other severe psychopathology or medical illness that would limit the participants' ability to comply with the demands of the current study (e.g. active psychotic disorder, cancer)
About Yeshiva University
Yeshiva University is a distinguished institution dedicated to advancing knowledge and innovation in healthcare through rigorous research and clinical trials. With a strong emphasis on integrating Jewish values and ethical considerations into scientific inquiry, the university fosters a collaborative environment that promotes interdisciplinary studies in medicine, biology, and health sciences. Yeshiva University aims to improve patient outcomes and contribute to the broader medical community by conducting high-quality clinical trials that adhere to the highest standards of integrity and scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported